| MACE | ACM | ||
---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | |
Univariate analysis | ||||
 Sex (F vs M) | 1.49 (1.02–2.18) | 0.038 | 1.40 (0.88–2.24) | 0.16 |
 Age | 1.05 (1.04–1.07) | 2.0 × 10−9 | 1.09 (1.06–1.11) | 1.9 × 10−12 |
 All multimorbidity | 2.69 (1.73–4.20) | 1.2 × 10−5 | 2.75 (1.56–4.84) | 4.8 × 10−4 |
 Number of drugs | 1.15 (1.10–1.21) | 2.0 × 10−8 | 1.14 (1.08–1.21) | 3.0 × 10−6 |
 Number of all interactions | 1.16 (0.995–1.34) | 0.058 | 1.01 (0.83–1.23) | 0.93 |
 Number of substantial interactions | 1.23 (0.997–1.51) | 0.053 | 1.11 (0.84–1.46) | 0.47 |
Multivariable analysis | ||||
 Age | 1.05 (1.03–1.07) | 8.9 × 10−7 | 1.08 (1.06–1.11) | 1.9 × 10−12 |
 All multimorbidity | 1.76 (1.10–2.82) | 0.019 | – | – |
 Number of drugs | 1.10 (1.04–1.16) | 1.2 × 10−3 | 1.12 (1.05–1.19) | 4.0 × 10−4 |